Neocleus Raises $11M Series B

JERSEY CITY, N.J. -- Neocleus, a pioneer in endpoint virtualization, today announced that it has raised $11.4M in Series B funding. Neocleus solutions create a more flexible, secure and efficient endpoint infrastructure. The round was led by Battery Ventures and Gemini Israel Funds, the company’s original investors.

Neocleus applies virtualization to desktops and laptops delivering the flexibility, manageability and security needed to address different user scenarios within a dynamic, dispersed enterprise. The company’s solutions, which include a Xen-based open source Type 1 bare-metal hypervisor for endpoints, enable critical IT tasks to operate in isolated, trusted virtual environments with complete access to the capabilities offered by the underlying endpoint hardware. This approach provides IT departments with a more agile and predictably secure virtual desktop environment and improves the overall cost of ownership of the endpoint.

“Neocleus is reinventing the endpoint, something that CIOs worldwide have been crying out for,” said Avi Domoshevizki, venture partner, Battery Ventures. “Enterprises today are burdened with rising endpoint support costs and an increasingly complex environment to secure and manage. Current virtualization solutions are insufficient because they either address only one issue or add complexity and cost. Neocleus’ novel approach changes the game to deliver a more agile infrastructure and reduce total cost of ownership of the endpoint. In addition, the company’s open source contributions are a catalyst for a new ecosystem that will further address the challenges facing IT departments. They have made tremendous progress since our initial investment, and we’re happy to continue to fuel their growth.”

Neocleus Inc.